DMAA saga ‘perfect example of gaping loophole in DSHEA which needs to closed’
date:May 11, 2012
d. That is, synthetically produced botanical ingredients should be not permitted to be sold as supplements[an argument made by the FDA in its draft guidance onnew dietary ingredients].

He added: Industry advocates would probably agree with me that[this]would require Congress to close that loophole.

Itsbeen an experiment - if synthetic botanicals are permitted, then would they be introduced responsibly? It appears to me that answer is no.

Draft guidance on NDIs and synthetic botanical constitu
3/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/01 02:00